Bone marrow stromal cells (BMSCs, also called bone-marrow-derived mesenchymal stromal cells) provide hematopoietic support and immunoregulation and contain a stem cell fraction capable of skeletogenic differentiation. We used immortalized human BMSC clonal lines for multi-level analysis of functional markers for BMSC subsets. All clones expressed typical BMSC cell-surface antigens; however, clones with trilineage differentiation capacity exhibited enhanced vascular interaction gene sets, whereas non-differentiating clones were uniquely CD317 positive with significantly enriched immunomodulatory transcriptional networks and high IL-7 production. IL-7 lineage tracing and CD317 immunolocalization confirmed the existence of a rare non-differentiating BMSC subtype, distinct from Cxcl12-DsRed + perivascular stromal cells in vivo. Colony-forming CD317 + IL-7 hi cells, identified at $1%-3% frequency in heterogeneous human BMSC fractions, were found to have the same biomolecular profile as non-differentiating BMSC clones using Raman spectroscopy. Distinct functional identities can be assigned to BMSC subpopulations, which are likely to have specific roles in immune control, lymphopoiesis, and bone homeostasis.
INTRODUCTION
Bone marrow stromal cells (BMSCs, also called bonemarrow-derived mesenchymal stromal cells) are heterogeneous populations that likely contain varying levels of tripotent (osteogenic, adipogenic, and chondrogenic [OAC] ) stem-cell-like cells; cells with restricted potency (bi-, uni-, and nullipotent), committed precursors, and other stromal cell types. Phenotypic variations probably reflect in vivo functional diversity and a biological requirement for distinct stromal subsets with specific roles in bone marrow maintenance. Single-cell-derived BMSC clone analysis has identified considerable variation in differentiation capacity, ranging from OAC tripotency to nullipotency in vitro (Muraglia et al., 2000; Okamoto et al., 2002; Russell et al., 2010 Russell et al., , 2011 and in vivo (Kuznetsov et al., 1997) , which may indicate the existence of BMSC subtypes with varied potencies and/or a hierarchical developmental progression. BMSCs also possess significant immunomodulatory characteristics and can influence all aspects of immune cell function via cell-cell interaction and immunoregulatory factor secretion (Nauta and Fibbe, 2007) , although clear demarcation between the skeletogenic and immunomodulatory capacity of BMSCs has not been made. Identification of human BMSCs often relies on non-discriminatory epitope detection (such as CD29, CD44, CD73, CD90
[THY-1], CD105, CD106 , and CD166) with lack of hematopoietic markers (such as CD34, CD14, and CD45) (Dominici et al., 2006) . Additional BMSC surface antigens have been described, including STRO-1 (Simmons and Torok-Storb, 1991) , CD146 (MCAM) (Sacchetti et al., 2007) , CD271 (LNGFR) (Quirici et al., 2002) , Nestin (Mén-dez-Ferrer et al., 2010) , platelet-derived growth factor receptor alpha (PDGFRa)/CD51 (Pinho et al., 2013) , LNGFR + THY-1 + VCAM-1 hi+ (Mabuchi et al., 2013) , and in mice, leptin receptor (LepR/CD295) (Zhou et al., 2014) . However, cellsorting experiments using these markers all show that they contain the colony-forming, differentiation-competent BMSC population, demonstrating that other, as yet undefined BMSC subtypes exist and further resolution of BMSC heterogeneity is required. In vitro studies of BMSC functionality are hindered by their limited lifespan as replicative senescence occurs during culture, thus limiting the number and depth of studies that can be performed.
To address these issues, we immortalized human BMSCs using human telomerase reverse transcriptase (hTERT), followed by clonal isolation to generate a panel of BMSC lines (hTERT-BMSCs). This strategy enabled in-depth, multiparameter analysis of variation in human BMSC subpopulations with different behavioral traits that subsequently could be examined in heterogeneous primary BMSCs. We unveil a range of biophysico-chemical markers for identification of different BMSC subsets with specific immunomodulatory and differentiation competencies.
RESULTS

Generation and Phenotyping of Variant hTERT Immortalized Clonal Cell Lines from Primary BMSCs
A heterogeneous population of primary bone marrow BMSCs was isolated from one donor (FH181) based on their strong growth properties and multilineage differentiation potential. A single donor was deliberately selected to guard against expected genetic/lifestyle factors that cause interdonor variation and would cloud interpretation of BMSC sub-population variation. A lentiviral expression system was used to overexpress hTERT in these cells, and stableexpressing lines were generated from single-cell-derived colonies. From numerous hTERT-BMSCs generated, our attention focused initially on four clonal lines selected for their strong clonal and stable growth characteristics (termed Y101, Y102, Y201, and Y202) that were maintained for over 400 days, showing exponential growth (Figure S1A) and elevated telomerase activity ( Figure S1B ). Their BMSC marker profile was determined by flow cytometry; all were positive for CD29, CD44, CD73, CD90, CD105, and CD166 and negative for CD34 and CD45 ( Figure 1A ), a profile matching their parental cells and typical of human primary BMSCs. All clones were also negative for CD11b, CD14, CD169, CD1a, CD4, CD11c, and CD83 (data not shown). It has been suggested previously that some BMSC lines may undergo oncogenic transformation either through hTERT transduction or extended time in culture (Serakinci et al., 2004) . We found no evidence of tumorigenicity in our hTERT-BMSCs using in vitro colony transformation assays for non-adherent growth ( Figure S1C ) or following subcutaneous injection into immunocompromised mice (data not shown). Distinct differences were observed in individual cell morphologies and single-cell-derived colonies: Y101 and Y201 shared characteristics that were distinct from Y102 and Y202 lines. Y101 and Y201 lines had elongated fibroblastoid morphology, typical of BMSCs, whereas Y102 and Y202 were flattened and spread. When plated at clonal density, Y101/Y201 cells consistently formed dispersed colonies with low cell contact, characteristic of a migratory phenotype, whereas Y102 and Y202 cells formed regular, high-density, compact colonies ( Figures 1B and S1D ). Morphological differences were quantified by image analysis, which demonstrated that Y202 cells had a statistically significantly greater area and perimeter compared to both the Y101 and Y201 cells. Y102 cells were also larger than the Y101/Y201; the mean cell perimeters for Y102, Y202, Y101, and Y201 were 273 ± 23, 317 ± 107, 202 ± 19, and 190 ± 34 mm, and mean cell areas were 1,537 ± 132, 1,649 ± 614, 1,067 ± 92, and 857 ± 214 mm 2 , respectively (Figures S1E and S1F). We identified variations in potency following OAC differentiation assays ( Figures 1C-1E ). Adipogenic media for up to 21 days induced the most potent observable and statistically significant adipogenic differentiation in Y201 cells at each time point, measured using the oil red O lipid-staining assay ( Figure 1C ). Y101 was also observed to differentiate into adipocytes, reaching significance at day 21, but Y102 and Y202 showed severely limited, although not completely absent, adipogenic potential, which was significantly different to Y201 at day 21. In addition, there were statistically significant increases in the levels of expression of the adipogenic genes peroxisome proliferator-activated receptor (PPAR)-g and lipoprotein lipase (LPL) in the Y201 cells cultured in adipogenic media at day 14 and day 21 compared to the time-matched untreated controls. At day 21, the expression level of both these genes was significantly lower in the three other cell lines ( Figure 1C ). Y101 and Y201 differentiated convincingly along osteogenic lineages and showed elevated alkaline phosphatase (ALP) activity with significantly increased calcium deposition by alizarin red staining ( Figure 1D ), which was statistically higher than Y102/Y202 clones, which showed minimal mineral deposition, although Y102 displayed elevated ALP activity ( Figure 1D ). Increases in ALP activity observed under basal conditions for Y101 and Y201 were replicated in qPCR analyses of the ALP gene ( Figure S1G ); further increases in ALP gene expression were clearly evident in the Y101 cell line under osteogenic conditions, while the levels in the other lines only showed modest increases. Furthermore, histological staining for elevated ALP activity was only observable in the Y101/ Y201 cells ( Figure S1G ). Gene expression analyses for RUNX2 showed that only the Y101/Y201 cell lines upregulated this early osteogenic marker at day 7 ( Figure 1D ). In response to chondrogenic induction using transforming growth factor b (TGF-b), only lines Y101 and Y201 displayed an early cell-condensation phenotype associated with chondrogenic induction (Johnson et al., 2012) , whereas no condensation was observed in similar micromass culture of lines Y102 and Y202 ( Figure 1E ). When cultures were stained with alcian blue and stain-associated glycosaminoglycans (GAGs) were eluted and quantified, significantly different levels were observed in all cell lines at day 9 compared to their time-matched controls under basal conditions, but the highest and statistically significant GAG levels were clearly evident in the Y101/Y201 compared to the Y102/Y202 cell lines. Similarly, only the Y101 and Y201 lines displayed marked increases in total GAG production under chondrogenic conditions in the Blyscan GAG assay ( Figure 1E ). Gene expression analyses for the early chondrogenic marker SOX9 confirmed that this marker only increased in the Y101/Y201 cell lines after 7 days in chondrogenic differentiation media ( Figure 1E ). Therefore, lines Y101/Y201 were capable of BMSC OAC differentiation, with Y201 showing stronger adipogenesis. The Y102/Y202 BMSC lines exhibited a non-hematopoietic, stromal phenotype with distinctive clonal behavior but with atypical BMSC morphology and limited differentiation ability compared to Y101/Y201.
Interrogation of Gene Expression Profiles Identifies Immune-Related BMSC Subtypes
We performed global gene expression analyses to identify distinguishing characteristics between the hTERT-BMSC clones and parental BMSCs; selecting significantly differentially expressed genes (p < 0.05, >2-fold change). Hierarchical clustering grouped Y101 with Y201 and closest to the primary parent BMSCs, while Y102/Y202 clustered separately ( Figure 2A ). Principal component analysis (PCA) revealed that 70% of the total variance was captured by the first two components ( Figure S2A ) and confirmed segregation of Y102/Y202 BMSC lines from the Y101/Y201 BMSC lines, the parent BMSC (FH181), and other primary BMSC populations ( Figure S2B ). Pathway analysis identified significant differences in expression of genes involved in the cell cycle, DNA replication, and other processes associated with cell replication, as would be predicted when comparing hTERT-immortalized lines with the parent sample ( Figure 2B ). Additional gene sets identified were involved in cell adhesion, endochondral ossification, and adipogenesis. Differentially expressed genes were notably enriched in pathways involved in Toll-like receptor, interferon, tumor necrosis factor a (TNF-a), interleukin-7 (IL-7) signaling, and inflammatory responses, implicating potential differences in the immunoregulatory properties between these lines ( Figure 2B ). Patterns of gene expression were also visualized and investigated using selforganizing heatmaps (SOMs). Expression data were used to produce mosaic fingerprints, and each mosaic tile represents metagenes that consist of mini-clusters of genes with similar expression placed in the same position across the mosaics ( Figure 2C ). Y101, Y201, Y102, and Y202 were compared against the primary parent BMSC source (FH181) and four others (FH469, FH348, FH359, and FH392). Primary BMSCs showed consistent spots of strong over-and under-expression in the bottom-right and top-left corners, respectively. Y101/Y201 and Y102/Y202 hTERT-BMSCs showed differences in patterns of expression at regions of over-and under-expression in the top right and bottom left of the SOMs, respectively ( Figure 2C , arrows, and Figures S2C and S2D ). The most significant gene sets overexpressed in Y101/201 versus Y102/202 were related to vascular growth (blood vessel remodelling, blood vessel development, artery morphogenesis, and patterning of blood vessels; Figure S2C ). Under-expressed Y101/Y201 gene sets that were most significantly over-represented in Y102/Y202 lines were immunomodulatory (antigen processing, MHC class II proteins, T cell signaling, and responses to interferon; Figure S2D ).
Further analysis found a strikingly elevated endogenous expression of inflammation-induced genes in the nondifferentiating lines Y102 and Y202 compared to the OAC-differentiation-competent BMSC clones ( Figure 2D ). By analyzing gene expression changes reported in a previously published dataset, where global gene expression was studied in adipose-derived BMSCs with or without stimulation with inflammatory cytokines (interferon g [IFN-g], TNF-a, and IL-6) (Crop et al., 2010) , we found that inflammation-induced genes were also elevated in unstimulated Y102 and Y202 cells compared to the Y101/ Y201 and parental BMSCs ( Figure 2D ). These observations pointed to the existence of a non-differentiating, resident stromal cell subset with ''unlicensed'' immunoregulatory potential associated with a pro-inflammatory response. The immunomodulatory effects of BMSCs are normally reported to be related to immunosuppression. In assays of immunosuppressive function, we found that all hTERT-BMSC lines were similarly capable of inhibiting anti-CD3/anti-CD28 antibody-stimulated peripheral blood mononuclear cell (PBMC) proliferation with no significant average quantified values ± SD for two or three independent experiments performed using two to six replicates. Differentiation was considered to be statistically significant after the data from n > 3 experiments were analyzed by one-way ANOVA with Holm Sidak's multiple comparisons if *p < 0.05, **p < 0.01, ***p < 0.001, or ****p < 0.0001 between both day 0 and the time-matched basal control. Additionally, one-way ANOVA with Holm Sidak's comparisons was performed between the different cell lines at day 21, and significant differences compared with Y101 ($) or Y102 ($) and Y201 (#) are indicated. See also Figure S1 . (legend continued on next page) differences of the inhibitory capacity of the cell lines at each BMSC:PBMC ratio used ( Figure S2E ). Similar increases in the expression of immunosuppressive factors (IDO1, TGFB1, and CD274) following exposure to TNF-a and IFN-g were observed in all hTERT-BMSC lines, but IL6 expression was significantly higher in the Y201 cells under TNF-a/IFN-g stimulation ( Figure S2F ). Y102/Y202 cells were significantly more responsive to inflammatory cytokine-induced expression of factors involved in lymphocyte homing and development, CXCL10 and IL-7. In particular, basal mRNA expression of IL-7 in Y102/Y202 cells was equivalent to expression levels in TNF-a/IFN-g-stimulated Y101/Y201 cells ( Figure S2F ). IL-7 signaling was highlighted as a differentially regulated pathway ( Figure 2B ), and we identified strong expression of IL-7 in Y102/Y102 compared to low IL-7 levels in Y101/Y201 by immunocytochemistry ( Figure 2E ). Using ELISAs, we confirmed significantly higher secretion of IL-7 in Y102/202 versus Y101/ Y201; heterogeneous primary BMSCs secreted low levels of IL-7, with negligible expression in human dermal fibroblasts ( Figure 2F) . No difference in IL-7 receptor expression level was observed by flow cytometry across the four cell lines (data not shown).
Together, these data indicate that OAC-competent BMSC clones expressed an extensive gene set consistent with vascular interaction; all BMSC lines showed broadly similar immunosuppressive features, while the poorly differentiating hTERT-BMSCs displayed a striking constitutive immunostimulatory expression profile and could be identified by elevated basal IL-7 expression, which has important functions in lymphopoiesis (Ceredig and Rolink, 2012) .
In Vivo Lineage Tracing of IL-7-Expressing Stromal Cells To identify and track IL-7-positive BMSC subpopulations in vivo, we used an IL-7Cre Rosa26-EYFP lineage-tracing mouse model, where enhanced yellow fluorescent protein (EYFP) expression persists in the progeny of cells that expressed IL-7 at any stage. EYFP-positive cells were found in bone marrow occasionally at perivascular and endosteallining locations but broadly distributed throughout the marrow with an $4% frequency ( Figures 3A-3F and S3A ). Using flow cytometry to discriminate CD45-expressing hematopoietic cells, we found the EYFP-positive stromal fraction represented $0.9% of the marrow cell population ( Figure S3B ). From histological sections, 91%, 77%, and 92%, respectively, of femoral, tibial, and calvarial osteocytes, terminally differentiated cells of the osteogenic lineage ( Figures 3D-3F and S3A) , and all perilipin-positive bone marrow cells and all adipocytes in white adipose tissue examined were EYFP negative ( Figures 3G-3L and S3C ). Strong EYFP positivity was confirmed in 11%-60% of articular chondrocytes ( Figures 3M-3O and S3A) , where IL-7 expression has been previously identified (Long et al., 2008) , and in 7%-31% of hypertrophic chondrocytes (Figure S3A ). These data demonstrate that a substantial proportion of mesodermal-derived adipose, bone, and cartilage tissues originate from a progenitor cell type that at no point expressed IL-7 and support the existence of poorly/nondifferentiating IL-7 hi BMSC subtype in vivo.
Identification of Y102/Y202-Related Subtypes in Primary BMSCs Y101/Y201 and Y102/Y202 lines were screened by flow cytometry in an attempt to identify a distinguishing cell-surface protein to sort from primary BMSC populations. We found little difference in expression of candidate BMSC markers CD271, CD51, and PDGFRa; while CD146 was largely undetectable on the Y201 line, its expression was similar in the other BMSC clones ( Figure 4A ). LepR/CD295 was expressed by both OAC-differentiating lines and the differentiation-incompetent lines ( Figure 4A ); in murine bone marrow, LepR/CD295 expression was found to be predominantly, though not exclusively, expressed by bone-and adipocyte-forming BMSCs (Zhou et al., 2014) . We analyzed the array data for differential expression of genes encoding cell-surface proteins; while ICAM1 and CD274 had similar protein expression profiles across all lines, CD317 was selectively and highly expressed in Y102 and Y202 cells and absent from Y101 and Y201 cells ( Figure 4A ). We examined another four BMSC clones (Y204, Y205, Y301, and Y302) generated during the initial hTERT immortalization experiments (Figure S4A) . They exhibited varying degrees of differentiation potency ( Figures S4B-S4H ), but none were differentiation incompetent across osteogenic, adipogenic, and chondrogenic lineages to the same degree as observed for Y102/Y202, and all were negative for CD317 (Figure S4I) . CD317 (also known as BST2/tetherin) has recognized anti-viral properties (Hotter et al., 2013) , and (E) Immunocytochemical detection of IL-7 expression (red) by the four hTERT-BMSC clones (after 24 hr in culture) (DAPI nuclear counterstain in blue). Scale bars, 20 mm. (F) IL-7 expression by ELISA in the four hTERT-BMSC clones, primary BMSCs (K98, K102, and K110), and human dermal fibroblasts (HDF). Data represent mean values ± SD from three individual experiments performed in duplicate. See also Figure S2 .
Y102/Y202 cells expressed elevated levels of several other anti-viral genes compared to Y101/Y201 and parent BMSCs ( Figure 4B ).
In low passage, primary BMSCs, a CD317-expressing population was detected in $1%-3% of the total cells (Figure S4J ). We used fluorescence-activated cell sorting (FACS) to sort the CD317 + fraction from CD317 À cells for further analysis and found that CD317 + cells were capable of density-independent growth and formed CFU fibroblasts (CFU-F) at a frequency similar to CD317 À cells ( Figure 4C ). Figure S4L ), while exposure of primary BMSCs to IFN-g for 24 hr resulted in an $3-fold increase in CD317 expression ( Figure S4M ). As marker expression can change with time in culture, we also sorted CD317-expressing cells from fresh, whole human bone marrow mononuclear cells (BM-MNCs); CD317 + cells in the stromal CD45 À CD31 À population represented on average 0.4% of the live cell population from two donors ( Figures S4N and S4O ). In mouse tissue sections, CD317 was expressed sporadically throughout the bone marrow (Figures 4F and S4P;  isotype control is shown in Figure S4Q ). CD317-positive cells rarely associated with CD31-positive vascular cells (Figures 4F and S4P) and did not generally colocalize with Cxcl12-DsRed + perivascular stromal and endothelial cells ( Figure 4F ).
The majority of bone marrow LepR-expressing cells lacked CD317 expression, though occasional LepR
were identified ( Figure 4G ). Collectively, these findings identify the presence of a rare, colony-forming population of BMSCs, marked by CD317 positivity, which appear to have an enhanced immunostimulatory capacity and are closely related to the Y102 and Y202 phenotype. We employed Raman spectroscopy to determine the extent of this relationship and provide a diagnostic evaluation of functional variation between BMSC subtypes. Averaged spectra were generated for each hTERT clonal line and primary CD317 + sorted BMSCs ( Figure 4H ), with their respective peak assignments identified as described previously (Movasaghi et al., 2007; Schulze et al., 2010) . Peak intensity ratios were obtained between all identified peaks for each cell type; the most discriminatory was found to be against the 1,088.6 cm À1 peaks. The 1,088.6 cm À1 peak is related to the symmetric phosphate stretch of the DNA backbone (Movasaghi et al., 2007) with its discrimination signifying a fundamental difference in the DNA of the cell types. This peak has also been used to discriminate other cell types, (Chan et al., 2006) . The 966cm -1 / 1088.6 cm À1 peak intensity ratios distinguished Y101 from Y201 ( Figure 4I , arrow). Other peak intensity ratios, most notably from 999.6 cm À1 and higher, clearly separated Y101/Y201 from Y102/Y202 ( Figure 4I ). Importantly, primary CD317 + cells mapped with remarkable consistency to the Y102/Y202 Raman profile ( Figure 4I ), providing strong evidence of relatedness.
DISCUSSION
We generated immortalized BMSC clones to perform detailed analysis of functional diversity in BMSC subtypes to levels not previously described. Similar immortalization techniques (e.g., hTERT combined with human papillomavirus E6/E7) have been used for the clonal analysis of BMSCs, which found OAC, AO, OC, unipotent, and nullipotent clones at varied frequencies, but other functional characteristics and discriminating features were not examined (Larsen et al., 2010; Okamoto et al., 2002) . Notably, however, enhanced immune-related features could be assigned to non-bone-forming hTERT-BMSCs in a previous study (Larsen et al., 2010) . Using non-immortalized BMSC clones, Muraglia et al. identified OAC-, OC-, and O-competent lines only, with very rare (<1%) nullipotent subsets (Muraglia et al., 2000) . Rather than determine occurrence of O/A/C phenotypes in heterogeneous BMSCs, here our aim was to identify molecular and biophysical markers of BMSC subtypes and their alignment with (legend continued on next page) non-progenitor cell functions, including immunomodulatory properties. To this end, from the original hTERT-BMSC lines generated, we selected four clones positioned at opposing ends of a differentiation competency scale, tripotent Y101/Y201 and relatively impotent Y102/Y202, for in-depth cell profiling. The OAC-differentiating lines expressed an extensive and significantly enriched gene set consistent with blood vessel support/interaction compared to nullipotent clones. This may reflect a relationship between BMSC differentiation competency and a perivascular niche location (Sacchetti et al., 2007 + cells by Raman spectroscopy, Raman shifts (H) and peak ratios (I) are shown. Raman peak assignments are provided in Table S2 . See also Figure S4 . stromal cells, again pointing to an alternative function for CD317 + BMSCs, unrelated to CXCL12-mediated hematopoietic stem cell niche support. CD317 has a welldefined anti-viral function acting to tether and restrict the release of viral particles and may also trigger the viral immune response (Hotter et al., 2013) . The existence of a marrow-resident, non-migratory, non-differentiating colony-forming stromal cell type, apparently primed for host defense, is an interesting concept. These cells could act as first responders to pathogen invasion and/or provide low-level immune control. As IL-7 has been implicated as a causative factor in autoimmunity, including rheumatoid arthritis (Dooms, 2013), unregulated control of CD317 + cell numbers and function may also contribute to disease onset and progression. These findings highlight the importance of identifying unique markers of BMSC sub-populations and assigning function, which will instruct strategies to analyze stromal-immune cell interaction, differentiation competency, and cell selection for safe and effective therapy.
EXPERIMENTAL PROCEDURES
Primary BMSC Isolation, Culture, and hTERT BMSC Production
All animal experiments and work involving human samples were approved by the University of York, Department of Biology ethics committee. Primary human BMSCs were isolated from femoral heads obtained with informed consent during routine hip replacement (see the Supplemental Experimental Procedures) or as explant cultures from human tibial plateaus after routine knee replacement. Cells were cultured in DMEM containing 15% fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin (changed every 3-4 days); cells were passaged at 70%-80% confluency. Cells were expanded and used between passage 1 (p1) and p5. The hTERT lentiviral vector was produced using ViraPower Lentiviral Gateway Expression Kit (Invitrogen), according to the manufacturer's guidelines, before transduction into primary human BMSCs isolated at p3 from the femoral head of a single donor. For selection of single cell lines, the transduced BMSCs were trypsinized and plated at 10 cells/cm 2 . Cells were grown in BMSC medium containing 20% HyClone serum at plating, then replaced with fresh media containing 15% HyClone serum every 3 or 4 days to day 14 (until discrete single-cell colonies were visible). Singlecell colonies were isolated and expanded.
For further information, see Supplemental Experimental Procedures. Okamoto, T., Aoyama, T., Nakayama, T., Nakamata, T., Hosaka, T., Nishijo, K., Nakamura, T., Kiyono, T., and Toguchida, J. Table S2 . Mean Raman peak assignments corresponding to the averaged spectra per cell line ( Figure   4H , I); maximum uncertainties in the peak measurements are ± 0.8 cm Table S3 . qPCR primer sequences
SUPPLEMENTAL INFORMATION
SUPPLEMENTAL TABLES
ALPL reverse TGGTCACAATGCCCACAGAT
RUNX2 forward GGTTAATCTCCGCAGGTCAC
RUNX2 reverse GTCACTGTGCTGAAGAGGCT
SOX9 forward TTCCGCGACGTGGACAT
SOX9 reverse TCAAACTCGTTGACATCGAAGGT
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Primary BMSC isolation and culture
Primary human BMSCs were isolated from femoral heads obtained with informed consent during routine hip replacement, as previously described (Dyson et al., 2007; Etheridge et al., 2004) , or as explant cultures from human tibial plateaus after routine knee replacement surgery. Cells were cultured in DMEM containing 15% FBS, 100U/mL penicillin and 100µg/mL streptomycin, which was changed every 3-4 days; cells were passaged at 70-80% confluency. Cells were expanded and used between passages (p)1 and p5.
hTERT BMSC production
The hTERT lentiviral vector was produced using the ViraPower Lentiviral Gateway Expression Kit (Invitrogen) according to manufacturer's guidelines, and as previously described (Saleh et al., 2012) before transduction into primary human BMSCs from a single donor. After clonal selection, the human telomerase gene was subcloned from pCI-neo-hEST2 (Addgene, courtesy of Robert Weinberg) into the pENTR 1A backbone provided using restriction enzyme digestion and ligation.
After appropriate screening, an LR recombination reaction was performed, successfully incorporating the hTERT gene into pLent6/V5-DEST lentiviral vector.
pLenti6/V5-DEST-hTERT lentiviral stocks were produced using 293FT cells according to manufacturer's instructions. 24hrs after lipofectamine transfection of pLenti6/V5-DEST-hTERT and viral packaging mix, culture media was replaced with 5ml fresh culture medium to concentrate viral particles. Lentivirus-containing medium was harvested 48hrs post-transfection, and lentiviral stocks were titered using the Lenti-X qRTPCR Titration Kit (Clontech).
BMSCs were transduced with pLenti6/V5-DEST-hTERT in the presence of 6µg/ml polybrene. After 16hrs the lentivirus-containing medium was removed and replaced with fresh BMSC media. After a further 24hrs, the cells were passaged and 2µg/ml blasticidin was added to the culture media. Media was replaced every 3-4 days with fresh blasticidin-containing medium for 12 days, when no living mock-transfected cells remained. To select single cell lines the transduced BMSCs were trypsinized and plated in 10cm plates at 10 cells/cm 2 . Cells were grown in BMSC medium containing 20%
HyClone serum for plating out the cells, then replaced with fresh BMSC medium containing 15%
HyClone serum every 3/4 days for 14 days (until discrete single cell colonies were visible). Single cell colonies were isolated using cloning cylinders, silicone grease, and trypsin-EDTA and then transferred to wells of 24-well plates. Once the cells reached 70% confluence they were passaged into 6-well plates, then 25cm 2 flasks, and finally 75cm 2 flasks for continued expansion. Cells were counted at each passage to determine population doubling time and maintained for continued culture in DMEM containing 10% FBS and antibiotics. Telomerase activity in hTERT-BMSCs was assessed using the TRAPeze® gel-based telomerase detection kit (Millipore) according to manufacturer's guidelines. Analyses using CellProfiler software were performed according to the designer instructions (www.cellprofiler.org).
In vitro hTERT BMSC differentiation
In vitro induction of BMSC differentiation was performed as previously outlined (Etheridge et al., 2004; Hoogduijn et al., 2006; Saleh et al., 2011) . Osteogenic differentiation was induced for up to 21
days with the addition of 5mM β--ascorbic acid phosphate and 10nM dexamethasone to growth media. Osteogenesis was assessed by both histological staining with alizarin red and quantitative elution of the stain alongside quantitative assays for alkaline phosphatase (ALP) activity (Cook et al., 2014; Hoogduijn et al., 2006) and gene expression analyses for Runx2 and ALP. Adipogenic differentiation was induced with 0.5mM isobutyl-methylxanthine, 1µg/ml insulin, 100µM indomethacin and 1µM dexamethasone for up to 21 days. Lipid accumulation was examined and quantified by Oil Red O staining (Cook et al., 2014) and gene expression analyses for
PPARγ and LPL were performed. Micromass pellet cultures were utilized for chondrogenesis assays.
Briefly, cells were trypsinized and resuspended to 2x10 7 cells/ml in serum-free media; 20µl cell suspension was placed in the middle of a culture well and allowed to adhere at 37°C for 3h. Wells were flooded with serum-free media containing 50µg/ml L-ascorbic acid phosphate, 100nM
dexamethasone, 40µg/ml L-proline, 1% ITS + , with or without TGF-β; medium was changed twice weekly. Chondrogenic differentiation was assessed using 9 day micromass cultures and potential was indicated through an early cell condensation phenotype (Johnson et al., 2012) . After 1, 6 or 9 days of culture, cells were fixed in 100% methanol (-20°C, 30 mins) , then incubated overnight with 0.5% alcian blue 8GS in 1M HCl (pH 0.2 to selectively stain highly sulphated glycosaminoglycans (GAGs) associated with cartilage tissue). Cells were washed extensively with distilled water before stereomicroscope visualisation. Specific GAG-associated stain was eluted from pellets by 6M guanidine incubation for 3 hours with rocking; supernatant absorbance was measured at 630nm. Total GAG content (pellet associated and secreted) for each cell line following chondrogenic induction was measured by the Blyscan glycosaminoglycan assay (Biocolor Ltd, UK) according to the manufacturer's instructions. Gene expression analyses by qPCR for the early chondrogenic marker
Sox9 were also performed.
Flow cytometry and cell sorting
Cell surface marker profiles were assessed on a CyAn flow cytometer and analyzed using Summit software (v4.3; Beckman Coulter). Cells were detached from culture plastic by incubation with PBS containing 0.2% BSA and 5mM EDTA, and stained with either directly conjugated primary antibodies, or successive incubations with optimised concentrations of primary antibody and an appropriate fluorescent-conjugated secondary antibody. All antibodies are listed in Table S1 . For cell sorting, BMSCs were processed and stained as above then sorted on a MoFlo Astrios high-speed, sterile cell sorter (Beckman Coulter). Cryopreserved, primary human bone marrow mononuclear cells (BM-MNCs) were purchased from Lonza (Belgium); both healthy donors were male Caucasians, donor one was 21 years of age, donor two was 22. Cells were thawed according to the Poietics protocol, rested for an hour before staining for 40mins with optimised concentrations of CD45, CD31
and CD317 antibodies or equivalent concentrations of isotype controls before sorting. Cells were also extracted from femora and tibiae bone marrow of IL-7cre Rosa26-EYFP mice and incubated with ACK buffer to lyse any red blood cells prior to flow cytometric analysis. CD317 staining was also assessed on primary cells after 50ng/ml recombinant human IFN-γ (PeproTech EC Ltd, UK) treatment for 24 hours.
Anchorage independent growth assay
Anchorage independent growth assays as an assessment of tumorigenic potential were performed on hTERT BMSC-lines alongside HEK-293 cells as positive controls and human dermal fibroblasts as a negative control. Cells were seeded into media containing 0.45% agarose in plates coated with 0.75% agarose and cultured for up to 21 days before imaging by brightfield microscopy.
RNA isolation and gene expression analysis
Total RNA was isolated from 80-90% confluent cultures using Macherey-Nagel Nucleospin RNA II kit. RNA quality was determined with the Agilent 2100 Bioanalyzer nano chip; high quality RNA samples were labelled using Agilent One Color Quick Amp labelling. Samples were processed for genome-wide gene expression analysis using the Agilent SurePrint G3 Human Gene Expression 8x60K v2 Microarray kit; triplicate arrays were performed on each cell line. All quality control checks met required standards. Data were analyzed using GeneSpring version 12.1 software (Agilent Technologies), using initial one-way ANOVA with controlling for multiple testing. This allowed for p-value adjustment lowering false discovery rate whilst maintaining sensitivity. Genes with a minimum two-fold difference in expression level and an adjusted p-value of <0.05 were considered differentially expressed. Subsequent pathway analysis was performed on lists of differentially expressed genes within the GeneSpring software. Additional analyses were performed using the statistical programming language R and the Bioconductor package limma.
Quantitative real-time PCR (qPCR) was performed using two protocols; the first used 500ng cDNA with the StepOnePlus™ Real-Time PCR System, TaqMan Universal PCR Master Mix and the assayon-demand primer/probes for IDO1 (Hs00158027.m1), IL6 (Hs00174131.m1), IL7 (Hs00174202.m1), IL10 (Hs00174086.m1), TGFB1 (Hs00171257.m1), CD274 (Hs00204257.m1), CXCL10 (Hs00171042.m1) and B2M (Hs00187842.m1) (all Applied Biosciences, Foster City, CA, USA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA served as endogenous control for normalization (Hs99999905.m1; Applied Biosciences). Intra-and inter-assay variations were determined by negative controls and positive reference samples. Changes in target gene expression relative to GAPDH were quantified using the comparative CT method. The second method used the SYBR green system and optimised amounts of cDNA reverse transcribed using superscript II (Invitrogen, UK) from 1µg of RNA isolated from primary BMSCs differentiated along the osteogenic, adipogenic or chondrogenic lineages using Trizol/chloroform extraction (Life Technologies, UK).
cDNA was amplified using Fast SYBR Green Master Mix (Life Technologies) and optimised primers (Table S3) for analysis of adipogenic genes (peroxisome proliferator-activated receptor gamma and lipoprotein lipase), osteogenic genes (alkaline phosphatase and RUNX2) or a chondrogenic gene (SOX9) using the StepOne real-time PCR system. Gene expression levels were quantified using the comparative CT (ΔΔCt) method and StepOne software v2.3 relative to the expression of the housekeeping gene RPS27a and normalized to d7 basal levels.
Agilent microarray data processing
Preprocessing of the microarray data was carried out using the statistical programming language R and the Bioconductor package limma. Firstly, background correction with optimal offset value was applied to the arrays to minimize signal related to non-specific fluorophore binding. The optimal offset value was evaluated by identifying which value stabilized the variances of probeset intensities the most. Quantile normalization was then applied to the arrays, which resulted in each array having the same empirical distribution of probeset intensity values, removing systematic variation from the data and scaling it so comparisons could be made between them. The values were then transformed by log 2 to control for variability in both highly and poorly expressed genes. Uninformative data such as control probesets and genes with low variance were also removed to decrease the false discovery rate (FDR). Lastly, the average expression levels from each of the replicates were collected into a global expression dataset.
Microarray data can be found on ArrayExpress: E-MTAB-3511 (release date: 03-August-2015).
Differential gene expression analysis
Differentially expressed genes were defined as those which exhibited a log fold-change of greater than two. The statistical significance of this differential expression was evaluated using a moderated ttest, known as Empirical Bayes. Instead of calculating an estimate of the variance for each gene, this moderated version calculates a global variance from the variances for all genes in the dataset. This is combined with an average of the variance for each gene producing a statistical test value that has a tdistribution. The Bioconductor package limma was used to calculate this log fold-change and significance value by applying a linear model to the probe set intensities for each gene using a least squares method. Limma also employed the Benjamini and Hochberg algorithm to control for the effects of multiple testing. This procedure allowed for the adjustment of the p-values and the lowering of the false discovery rate whilst keeping the sensitivity for true positive results. Genes with a twofold difference in expression levels and with an adjusted p-value of ≤0.05 between any pair of cell lines in the dataset were considered as significantly differentially expressed. The differentially expressed genes limma outputs were then collected into a differential expression dataset for use in subsequent analyses.
Sample and gene clustering algorithms
A preliminary insight into the variation of gene expression profiles between cell lines was achieved by performing principal component analysis (PCA) on the differential expression dataset using the R CRAN package stats. This approach reduces the dimensionality of the dataset into two orthogonal variables, visualised as a two-dimensional scatterplot of the cell lines. Cell lines that cluster close together in two-dimensional space are considered to have more similar expression profiles than those further away.
SOM-mapping of global expression profiles
Self-organizing map (SOM) machine learning was applied to the global expression dataset using the R CRAN package oposSOM (Wirth et al., 2011) . This unsupervised learning method uses neural networks to reduce high dimensional data onto a two-dimensional mosaic. Each tile on the mosaic represents a metagene consisting of mini-clusters of genes with similar expression profiles. Genes are assigned to clusters using the minimum Euclidian distance and metagenes with similar expression profiles are positioned next to each other. Because the same metagene is assigned to the same tile in SOMs across all samples, direct visual comparisons of global expression can be made and areas of notable over-or under-expression are readily observed. After running the analysis, oposSOM outputs a SOM for each cell line, a combined SOM of over-and under-expressed metagene hotspots, including a list of genes which contribute to those metagenes and their relative expression in each cell line.
Gene set over-representation analysis
Gene set over-representation analysis was used to help define the functional nature of the respective spots. For each of the spots the degree of over-representation of 1454 pre-defined gene sets was measured using the hypergeometrical distribution (Wirth et al., 2011) . This assigns the probability that members of a certain gene set are present in a list of genes compared against the random chance of their appearance independent of expression values. Gene sets contain lists of genes which have been shown to act in the same pathway or appear to be coexpressed. An over-representation p-value is then used to evaluate the significance of over-representation of each gene set to each metagene. The hypergeometrical distribution then ranks the list of gene sets by decreasing significance of overrepresentation for the spots. In addition, gene ontologies were used to describe the attributes of each gene product in these hotspots. Gene ontologies provide a comprehensive and unified way of annotating gene products with i) the biological process to which they contribute ii) their functional biochemical activity iii) the cellular component where they are active (Ashburner et al., 2000) . Using a hypergeometrical distribution, the statistical over-representation of these terms with regards to the global expressed set was also calculated. Again, oposSOM was used to carry out this analysis, and
given the row names of the expression dataset are labelled using ENSEMBL gene IDs is automatically performed when the function is called.
Immunofluorescent staining for IL-7
To identify IL-7 immunopositivity in hTERT-BMSCs, 2x10 4 cells were seeded onto coverslips, allowed to adhere overnight then fixed in 4% PFA for 5mins at 21°C before permeabilization with 0.1% Triton X-100 in PBS and blocking of endogenous peroxidase activity with 1% H 2 O 2 . All future steps were performed at room temperature in a humidified chamber in the presence of 1% blocking reagent supplied with the tyramide signal amplification kit. Extensive washes were performed between antibodies; all reagents were from Invitrogen unless otherwise stated. Samples were initially blocked for 30mins in PBS containing 1% blocking reagent before incubations for 60mins with optimised concentrations of either mouse anti-human IL-7 primary antibody (R&D clone 7417/catalogue number MAB207) or an IgG1 isotype control. Coverslips were incubated with 1:200 biotinylated anti-mouse secondary antibody for 30mins before incubation with 1:100 diluted horseradish peroxidase for 45mins. Alexa Fluor-647 conjugated tyramide was 1:100 diluted in amplification buffer and incubated with the samples for 5mins. Finally, samples were extensively washed before mounting in Prolong gold containing DAPI and imaged using an LSM710 invert confocal microscope (Carl Zeiss).
In vivo IL-7 lineage tracing
IL-7cre Rosa26-EYFP mice were bred under pathogen free conditions at the University of York (Repass et al., 2009 ). All work was in accordance with ethical approvals from the University of York and Home Office License 60/4169. For lineage tracing experiments, tissues from IL-7cre Rosa26-EYFP mice were fixed in 4% PFA overnight and placed at room temperature in 30% sucrose solution for 15mins followed by 15% sucrose overnight at 4°C. Tissues were then coated with 10% polyvinyl alcohol (PVA) and frozen in cooled isopropanol on dry ice. They were then fully mounted in 10%
ostat, slide-mounted and observed by fluorescence microscopy.
Immunohistochemistry
Bone samples from the femurs of 11-or 12-week old female hybrid C57BL/Ka x C57BL/6 mice (derived from in-house crossing of Cxcl12 tm2.1Sjm
/J (The Jackson Laboratory) and wild-type C57BL/6 mice) or IL-7cre Rosa26-EYFP and non-EYFP expressing mice were used. These mice express DsRedE2 under control of the Cxcl12 promoter (Ding and Morrison, 2013) or IL-7 EYFP, respectively. Samples were fixed overnight at 4°C in 4% paraformaldehyde/75mM lysine/10mM periodate fixative. Bones were decalcified for 3 days in 10% EDTA, 0.1M Tris, pH7.2 at 4°C with agitation before overnight incubation in 30% sucrose in PBS at 4°C and embedding in optimal cutting temperature embedding media (Tissue-Tek). 5µm sections were cut, applied to slides and blocked for 1hr at room temperature in staining buffer (PBS + 0.05% BSA + 5% species specific serum) before staining with optimised concentrations of primary antibodies in staining buffer at 4°C overnight.
Three five-minute washes (PBS + 0.05% BSA) were performed before slides were incubated with optimised concentrations of relevant secondary antibody for 1hr at RT. Where indicated, anti-GFP tag antibody was applied for 1hr. Three further washes, DAPI counterstaining and prolong gold mounting (Invitrogen) were performed before imaging using an LSM710, LSM780 or LSM 510 confocal microscopes (Carl Zeiss) and image analysis with Zen 2012 (blue edition) software (Carl Zeiss).
ELISA for IL-7 secretion
Cells were seeded into 6 well plates at 2x10 4 cells/cm 2 and left to adhere overnight. Culture media was replaced with 2ml fresh media; 24h later the quantity of IL-7 in the supernatant was measured using the Quantikine HS Human IL-7 Immunoassay (R&D systems) according to the manufacturer's guidelines, and compared against medium alone.
Peripheral blood mononuclear cell (PBMC) proliferation assay
PBMCs were incubated with the hTERT-BMSCs at ratios of 1:5, 1:10, 1:20 and 1:40. PBMC proliferation was quantified by detection of 3 H-thymidine incorporation into the PBMCs after three days of stimulation with anti-CD3 anti-CD28 antibodies.
Raman Methods
The hTERT BMSCs and CD317+ cells were seeded at 5x10 4 cells per CaF 2 microscope slide; slides were incubated in growth media with 0.1% amphotericin B for 24h before replacement with DMEM containing 0.5% FBS and another 24h incubation for G 0 synchronisation. Before Raman analysis, slides were PBS rinsed twice and air-dried. Raman spectra were collected using a HORIBA XploRA micro-Raman instrument with 532nm laser wavelength and x100 objective (NA = 0.9) in confocal setting. Spectra were acquired ambiently using 45s laser exposure resulting in 3.5mW power at the sample. Each measurement was obtained using a 2400 lines/mm diffraction grating, with the results averaged over 2 spectral acquisitions over the 'finger-print' range (600cm -1 to 1800cm -1 ). Raman spectra were collected from hTERT BMSC lines using 20 randomly selected cells, with five randomly selected points taken in the nucleus of each cell. The resulting 100 spectra per BMSC line were baseline-corrected and averaged so that a representative spectrum of each BMSC population was obtained. For the CD317+ cell line, a Raman spatial map consisting of 172 spectra across the nucleus was acquired. These spectra were baseline-corrected and averaged to obtain a representative spectrum of the individual CD317+ cell under investigation. To prevent laser-induced cell damage, Raman spectra were monitored during real-time data acquisition, with optical inspection also being performed after each Raman measurement. All spectra were collected using the LabSpec 5 software (HORIBA).
Baseline-correction was performed to each spectrum using an interval linear fitting method obtained in the 'Raman tool set' software (Candeloro et al., 2013) . Further analysis on the averaged spectra, including individual peak baselines and Gaussian peak fitting, was conducted using IGOR Pro 6.32.
Raman markers were determined from the set of two-peak intensity ratios derived from key peaks in the averaged cell spectra.
Data Analysis
Data were analysed in GraphPad Prism v6.05; statistical analyses using 2way ANOVA followed by Sidak's multiple comparisons, paired t-test or 1way ANOVA with relevant multiple comparison test were used, where indicated.
